Surface modification of HSA containing magnetic PLGA nanoparticles by poloxamer to decrease plasma protein adsorption

Colloids Surf B Biointerfaces. 2014 Oct 1:122:529-536. doi: 10.1016/j.colsurfb.2014.07.025. Epub 2014 Jul 22.

Abstract

Lifetime prolongation for hydrophobic drug carriers has been the focus of interest for many years. Poloxamer (Pluronic F68, PF68) has been employed in this study for modifying the surface of magnetic poly(d,l-lactic-co-glycolic acid) (PLGA) nanoparticles (NPs) loaded with human serum albumin (HSA) model drug. Surface characteristics of untreated and PF68 treated NPs were analyzed by size, zeta potential and electrophoretic mobility studies. UV-vis spectroscopic analysis, isothermal titration calorimetry (ITC) and dynamic light scattering methods were used to investigate serum protein (bovine serum albumin, BSA) adsorption. Results showed the successful surface attachment of PF68. Among different concentrations (0.1-1%, wt/vol) of PF68 studied, 0.5% was found to be the most useful, since a higher concentration can issue in micelle formation. 50% less BSA tended to be adsorbed on the treated NPs in comparison to the untreated ones.

Keywords: Isothermal titration calorimetry; Poloxamer; Protein adsorption; Surface modification.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adsorption
  • Calorimetry
  • Electrophoretic Mobility Shift Assay
  • Lactic Acid / chemistry*
  • Magnetics
  • Nanoparticles*
  • Polyglycolic Acid / chemistry*
  • Polylactic Acid-Polyglycolic Acid Copolymer
  • Serum Albumin / chemistry*
  • Spectrophotometry, Ultraviolet
  • Surface Properties

Substances

  • Serum Albumin
  • Polylactic Acid-Polyglycolic Acid Copolymer
  • Polyglycolic Acid
  • Lactic Acid